← Browse by Condition
Medical Condition
autoimmune encephalitis
Total Trials
7
Recruiting Now
7
Trial Phases
EARLY_Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for autoimmune encephalitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — autoimmune encephalitis Clinical Trials
How many clinical trials are currently recruiting for autoimmune encephalitis?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for autoimmune encephalitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for autoimmune encephalitis?
autoimmune encephalitis research spans Phase 1 (2 trials), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a autoimmune encephalitis clinical trial?
Eligibility criteria for autoimmune encephalitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06079294
Recruiting
Enrollment
56 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06019975
Recruiting
Enrollment
90 pts
Location
Italy
Sponsor
University of Milano Bicocca
NCT05772611
Recruiting
Enrollment
180 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06939166 EARLY_Phase 1
Recruiting
Enrollment
12 pts
Location
China
Sponsor
Tianjin Huanhu Hospital
NCT06173076
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Shen Chun-Hong
NCT07093333 Phase 2
Recruiting
Enrollment
30 pts
Location
South Korea
Sponsor
Arialys Australia Pty Ltd
NCT04561557 EARLY_Phase 1
Recruiting
Enrollment
36 pts
Location
China
Sponsor
Tongji Hospital
Related Conditions
myasthenia gravis (2) multiple sclerosis (2) chronic inflammatory demyelinating polyradiculoneuropathy (2) paraneoplastic neurological syndrome (1) neuromyelitis optica spectrum disorders (1) leucine rich glioma inactivated 1 autoimmune encephalitis (1) anti n methyl d aspartate receptor nmdar encephalitis anre (1) anti n methyl d aspartate receptor nmdar antibody associated psychiatric disease (1) autoimmune diseases (1) autoimmune diseases of the nervous system (1) neuromyelitis optica spectrum disorder (1) idiopathic inflammatory myopathies (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology